Study record

Neural cell-derived plasma exosome protein abnormalities implicate mitochondrial impairment in first episodes of psychosis

Goetzl EJ, Srihari VH, Guloksuz S et al. · FASEB J · 2021

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

Measured mitochondrial proteins in plasma neural-derived extracellular vesicles and found lower MOTS-c and humanin levels in people with first-episode psychosis than in matched controls, alongside lower mitofusin 2 and cyclophilin D. MOTS-c was one of many mitochondrial proteins quantified rather than the study's main focus.

Limitations

Very small sample with ten participants per group, cross-sectional design, and no correction described for multiple comparisons across the many proteins measured; extracellular-vesicle protein levels are an indirect proxy for neural mitochondrial status.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedPlasma neuron-derived and astrocyte-derived extracellular vesicles from people with first-episode psychosis and matched controls
Populationadults with first-episode psychosis and matched psychiatrically normal controls
DesignCase-control study
Sample size as reported20 participants (10 first-episode psychosis, 10 controls)
Control groupten matched psychiatrically normal controls
Route (data field only)Not reported
Endpoints measuredexosomal MOTS-c; exosomal humanin; mitochondrial ATP synthase activity; mitofusin 2; cyclophilin D
Pathways measuredOther
Research areasNervous system · Mitochondrial biology
Evidence tierB — Other human study
Publication typesJournal Article, Research Support, N.I.H., Extramural

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Peripheral
Model applicability
Human
Sample size
Small
Controls
Appropriate
Outcome validity
Exploratory
Support for its own conclusion
Weak

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.